Related Articles
Association between EGFR/KRAS mutation and expression of VEGFA, VEGFR and VEGFR2 in lung adenocarcinoma
Genetic features and application value of next generation sequencing in the diagnosis of synchronous multifocal lung adenocarcinoma
Postrecurrence survival of surgically resected pulmonary adenocarcinoma patients according to EGFR and KRAS mutation status
Heterogeneity in the colorectal primary tumor and the synchronous resected liver metastases prior to and after treatment with an anti-EGFR monoclonal antibody
Determination of EGFR and KRAS mutational status in Greek non‑small‑cell lung cancer patients